Log In

Healthcare & Pharmaceuticals Blog

Recent Posts

  • Blog: Homeostasis: Dykema Health Care Law BlogNew Merger Guidelines Could Have Significant Impact on Healthcare TransactionsPosted on January 20, 2022 by James Burns
    The Federal Trade Commission and the DOJ Antitrust Division recently announced that they would be reviewing, and likely revising, the Horizontal Merger Guidelines  – the guidelines used by the agencies when assessing whether a proposed transaction may have adverse impacts on competition. (The announcement, issued on January 18, is available here).  In announcing the change,... Continue Reading
    READ FULL ARTICLE
  • Blog: ALTIUS BlogsInfluencer marketing: 5 tips for your influencer contractsPosted on January 13, 2022 by
    Influencer marketing is a form of marketing in which companies use the online influence and relevant knowledge of people called “influencers”. Influencers are present on one or more social networking platforms and have a community of subscribers who follow their content (posts, photos, videos, stories, etc.). Different actors play a role in influencer marketing: companies wishing to promote their products or services, influencers, advertising agencies, consumers, and of course the platforms that connect all these people. In this blog post, we present five tips that companies should keep in m...
    READ FULL ARTICLE
  • Blog: Patent 213Another Gaming Patent Struck Down as IneligiblePosted on July 19, 2021 by Stephanie D. Scruggs
    Bot M8 LLC, a patent assertion entity, was unsuccessful in its effort to have the Federal Circuit reverse the lower court’s invalidity finding related to one of six different patents asserted against Sony in Northern District of California. In fact, the Federal Circuit was so unpersuaded by Bot M8’s arguments that it devoted less than...
    READ FULL ARTICLE
  • Blog: Biologics BlogFederal Circuit Upholds Jury Award, Weighs in on Willfulness Standard, in Adynovate® DisputePosted on March 29, 2021 by
    According to the Federal Circuit, $173 million was the right damages award for almost three years of patent infringement resulting from Baxalta’s sale of its biologic product Adynovate® (Antihemophilic Factor (Recombinant), PEGylated).  In Bayer Healthcare LLC v. Baxalta Inc., et al., Nos. 2019-2418, 2020-1017 (Fed. Cir. 2021), the circuit court upheld an award to Bayer [...]
    READ FULL ARTICLE
  • Blog: Chemical Law & Prop 65 BlogMajor Changes Coming to Prop 65 “Short-Form” WarningsPosted on February 1, 2021 by
    By: Anne Marie Ellis, John Epperson, Peter McGaw
    READ FULL ARTICLE

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2020